e-learning
resources
London 2016
Tuesday, 06.09.2016
Biomarkers and phenotypes of COPD and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD
Wafaa Gadallah (Assiut, Egypt), Wafaa Gadallah, Atef Farouk, Abd Elazeem Aboelfadl, Manal Alkhawaga
Source:
International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Session:
Biomarkers and phenotypes of COPD and comorbidities
Session type:
Poster Discussion
Number:
4620
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Wafaa Gadallah (Assiut, Egypt), Wafaa Gadallah, Atef Farouk, Abd Elazeem Aboelfadl, Manal Alkhawaga. Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD. Eur Respir J 2016; 48: Suppl. 60, 4620
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Body-plethysmographic measurements of bronchodilator response in stable COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
Bronchodilator response of advanced lung function parameters depending on COPD severity
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Comparison of protective effect of bronchodilators in COPD
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015
First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Evaluation of bronchodilator responses in patients with "irreversible" emphysema
Source: Eur Respir J 2001; 18: 914-920
Year: 2001
Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
FEV
6
as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013
Lung hyperinflation in COPD: the impact of pharmacotherapy
Source: Eur Respir Rev 2006; 15: 85-89
Year: 2006
Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Bronchodilation test estimation using spirometry and electrical impedance analysis in bronchial asthma and COPD patients
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
Can emphysema predict exacerbations and changes in PFTs in COPD?
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Concordance between oscillometric and spirometric lung function measures in bronchodilator response test for the detection of airway obstruction
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016
Non-contact assessment of acute bronchodilator’ response during tidal breathing in COPD patients using structured light plethysmography (SLP)
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET
Source: ERJ Open Res, 6 (3) 00092-2020; 10.1183/23120541.00092-2020
Year: 2020
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction?
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Single-breath washout in stable COPD patients: Association with bodyplethysmography and bronchodilator response
Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept